|
QLT Widens Loss in Q1
Zacks.com Visudyne is used for treating abnormal growth of leaky blood vessels in the eye caused by wet age-related macular degeneration. Research and development expenses at QLT came in at $4.8 million in the first quarter of 2014 compared with $4.1 million in … |
Source: Wet Macular Degeneration News From Google News
Zennie Abraham | Zennie Abraham or “Zennie62” is the founder of Zennie62Media which consists of zennie62blog.com and a multimedia blog news aggregator and video network, and 78-blog network, with social media and content development services and consulting. Zennie is a pioneer video blogger, YouTube Partner, social media practitioner, game developer, and pundit. Note: news aggregator content does not reflect the personal views of Mr. Abraham.